{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:47:28Z","timestamp":1791478048118,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-120"],"award-info":[{"award-number":["2022-PUMCH-B-120"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00415-023-12128-9","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T13:02:19Z","timestamp":1703336539000},"page":"1072-1079","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prognostic and relapsing factors of primary autoimmune cerebellar ataxia: a prospective cohort study"],"prefix":"10.1007","volume":"271","author":[{"given":"Mange","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,23]]},"reference":[{"key":"12128_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s12311-020-01132-8","volume":"19","author":"M Hadjivassiliou","year":"2020","unstructured":"Hadjivassiliou M, Graus F, Honnorat J, Jarius S, Titulaer M, Manto M, Hoggard N, Sarrigiannis P, Mitoma H (2020) Diagnostic criteria for primary autoimmune cerebellar ataxia-guidelines from an international task force on immune-mediated cerebellar ataxias. Cerebellum 19:605\u2013610. https:\/\/doi.org\/10.1007\/s12311-020-01132-8","journal-title":"Cerebellum"},{"key":"12128_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-021-01363-3","author":"S Mu\u00f1iz-Castrillo","year":"2022","unstructured":"Mu\u00f1iz-Castrillo S, Vogrig A, Ciano-Petersen NL, Villagr\u00e1n-Garc\u00eda M, Joubert B, Honnorat J (2022) Novelties in autoimmune and paraneoplastic cerebellar ataxias: twenty years of progresses. The Cerebellum. https:\/\/doi.org\/10.1007\/s12311-021-01363-3","journal-title":"The Cerebellum"},{"key":"12128_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11946-1","author":"A Kudo","year":"2023","unstructured":"Kudo A, Yaguchi H, Tanaka K, Kimura A, Yabe I (2023) A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution. J Neurol. https:\/\/doi.org\/10.1007\/s00415-023-11946-1","journal-title":"J Neurol"},{"key":"12128_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15161","author":"V Damato","year":"2021","unstructured":"Damato V, Papi C, Spagni G, Evoli A, Silvestri G, Masi G, Sabatelli E, Campetella L, McKeon A, Andreetta F, Riso V, Monte G, Luigetti M, Primiano G, Calabresi P, Iorio R (2021) Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the scale for the assessment and rating of ataxia. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.15161","journal-title":"Eur J Neurol"},{"key":"12128_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12974-015-0356-y","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B (2015) \u2018Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj\/ITPR1 and anti-CARP VIII. J Neuroinflammation 12:166. https:\/\/doi.org\/10.1186\/s12974-015-0356-y","journal-title":"J Neuroinflammation"},{"key":"12128_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-015-0357-x","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B (2015) \u2018Medusa head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca\/ARHGAP26 and anti-VGCC. J Neuroinflammation 12:167. https:\/\/doi.org\/10.1186\/s12974-015-0357-x","journal-title":"J Neuroinflammation"},{"key":"12128_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12974-015-0358-9","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B (2015) \u2018Medusa head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo\/CDR2, anti-Nb\/AP3B2, PCA-2, anti-Tr\/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation 12:168. https:\/\/doi.org\/10.1186\/s12974-015-0358-9","journal-title":"J Neuroinflammation"},{"key":"12128_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-020-01152-4","author":"M Hadjivassiliou","year":"2020","unstructured":"Hadjivassiliou M, Grunewald RA, Shanmugarajah PD, Sarrigiannis PG, Zis P, Skarlatou V, Hoggard N (2020) Treatment of primary autoimmune cerebellar ataxia with mycophenolate. Cerebellum. https:\/\/doi.org\/10.1007\/s12311-020-01152-4","journal-title":"Cerebellum"},{"key":"12128_CR9","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jamaneurol.2015.2378","volume":"72","author":"AL Jones","year":"2015","unstructured":"Jones AL, Flanagan EP, Pittock SJ, Mandrekar JN, Eggers SD, Ahlskog JE, McKeon A (2015) Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults. JAMA Neurol 72:1304\u20131312. https:\/\/doi.org\/10.1001\/jamaneurol.2015.2378","journal-title":"JAMA Neurol"},{"key":"12128_CR10","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s12311-019-01048-y","volume":"18","author":"Z Weihua","year":"2019","unstructured":"Weihua Z, Haitao R, Fang F, Xunzhe Y, Jing W, Hongzhi G (2019) Neurochondrin antibody serum positivity in three cases of autoimmune cerebellar ataxia. Cerebellum 18:1137\u20131142. https:\/\/doi.org\/10.1007\/s12311-019-01048-y","journal-title":"Cerebellum"},{"key":"12128_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-022-01412-5","author":"M Liu","year":"2022","unstructured":"Liu M, Ren H, Zhu Y, Fan S, Bai L, Wang J, Cui L, Guan H (2022) Autoimmune cerebellar ataxia: etiology and clinical characteristics of a case series from China. Cerebellum. https:\/\/doi.org\/10.1007\/s12311-022-01412-5","journal-title":"Cerebellum"},{"key":"12128_CR12","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000633","author":"X Xu","year":"2020","unstructured":"Xu X, Lu Q, Huang Y, Fan S, Zhou L, Yuan J, Yang X, Ren H, Sun D, Dai Y, Zhu H, Jiang Y, Zhu Y, Peng B, Cui L, Guan H (2020) Anti-NMDAR encephalitis: a single-center, longitudinal study in China. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000633","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12128_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157\u2013165. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1","journal-title":"Lancet Neurol"},{"key":"12128_CR14","doi-asserted-by":"publisher","first-page":"175628642110732","DOI":"10.1177\/17562864211073203","volume":"15","author":"K Guo","year":"2022","unstructured":"Guo K, Liu X, Lin J, Gong X, Li A, Liu Y, Zhou D, Hong Z (2022) Clinical characteristics, long-term functional outcomes and relapse of anti-LGI1\/Caspr2 encephalitis: a prospective cohort study in Western China. Ther Adv Neurol Disord 15:17562864211073204. https:\/\/doi.org\/10.1177\/17562864211073203","journal-title":"Ther Adv Neurol Disord"},{"key":"12128_CR15","first-page":"iii","volume-title":"Autoimmune Encephalitis and Related Disorders of the Nervous System","author":"F Graus","year":"2022","unstructured":"Graus F, Dalmau J (2022) Autoimmune Encephalitis and Related Disorders of the Nervous System. In: Graus F, Dalmau J (eds) Autoimmune Encephalitis and Related Disorders of the Nervous System. Cambridge University Press, Cambridge, pp iii\u2013iii"},{"key":"12128_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157\u2013165. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1","journal-title":"Lancet Neurol"},{"key":"12128_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001131","author":"A Mehdiyeva","year":"2022","unstructured":"Mehdiyeva A, Hietaharju A, Sipil\u00e4 J (2022) SEZ6L2 antibody-associated cerebellar ataxia responsive to sequential immunotherapy. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001131","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12128_CR18","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001088","author":"FS Thaler","year":"2021","unstructured":"Thaler FS, Zimmermann L, Kammermeier S, Strippel C, Ringelstein M, Kraft A, S\u00fchs K-W, Wickel J, Geis C, Markewitz R, Urbanek C, Sommer C, Doppler K, Penner L, Lewerenz J, R\u00f6\u00dfling R, Finke C, Pr\u00fcss H, Melzer N, Wandinger K-P, Leypoldt F, K\u00fcmpfel T (2021) Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001088","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12128_CR19","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamaneurol.2021.3188","volume":"78","author":"M Nosadini","year":"2021","unstructured":"Nosadini M, Eyre M, Molteni E, Thomas T, Irani SR, Dalmau J, Dale RC, Lim M, Anlar B, Armangue T, Benseler S, Cellucci T, Deiva K, Gallentine W, Gombolay G, Gorman MP, Hacohen Y, Jiang Y, Lim BC, Muscal E, Ndondo A, Neuteboom R, Rost\u00e1sy K, Sakuma H, Sartori S, Sharma S, Tenembaum SN, Van Mater HA, Wells E, Wickstrom R, Yeshokumar AK (2021) Use and safety of immunotherapeutic management of N-methyl-d-aspartate receptor antibody encephalitis: a meta-analysis. JAMA Neurol 78:1333\u20131344. https:\/\/doi.org\/10.1001\/jamaneurol.2021.3188","journal-title":"JAMA Neurol"},{"key":"12128_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-023-06968-6","author":"M Liu","year":"2023","unstructured":"Liu M, Xu X, Fan S, Ren H, Zhao Y, Guan H (2023) Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma-inactivated protein 1 encephalitis: a prospective observational cohort study. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-023-06968-6","journal-title":"Neurol Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12128-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-12128-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12128-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T08:09:06Z","timestamp":1708934946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-12128-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,23]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["12128"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-12128-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,23]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}